Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and reactogenicity of Poliorix booster in toddlers (China)
2017-001608-32Phase 3
- Sponsor
- GSK
- Start
- Nov 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Poliorix in poliomyelitis, sponsored by GSK. Primary endpoint: Solicited local and general symptoms.
02
Drugs
Poliorix
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2017-001608-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001608-32.